JP2015145364A5 - - Google Patents

Download PDF

Info

Publication number
JP2015145364A5
JP2015145364A5 JP2015020091A JP2015020091A JP2015145364A5 JP 2015145364 A5 JP2015145364 A5 JP 2015145364A5 JP 2015020091 A JP2015020091 A JP 2015020091A JP 2015020091 A JP2015020091 A JP 2015020091A JP 2015145364 A5 JP2015145364 A5 JP 2015145364A5
Authority
JP
Japan
Prior art keywords
cyclodextrin
cyclodextrins
group
composition
mixtures
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015020091A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015145364A (ja
JP6095707B2 (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2015145364A publication Critical patent/JP2015145364A/ja
Publication of JP2015145364A5 publication Critical patent/JP2015145364A5/ja
Application granted granted Critical
Publication of JP6095707B2 publication Critical patent/JP6095707B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015020091A 2011-11-29 2015-02-04 薬学的組成物 Active JP6095707B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
AU2011904970A AU2011904970A0 (en) 2011-11-29 Pharmaceutical compositions
AU2011904970 2011-11-29
AU2012904962 2012-11-09
AU2012904962A AU2012904962A0 (en) 2012-11-09 Pharmaceutical compositions

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2014542644A Division JP5819005B2 (ja) 2011-11-29 2012-11-27 薬学的組成物

Publications (3)

Publication Number Publication Date
JP2015145364A JP2015145364A (ja) 2015-08-13
JP2015145364A5 true JP2015145364A5 (cg-RX-API-DMAC10.html) 2016-01-07
JP6095707B2 JP6095707B2 (ja) 2017-03-15

Family

ID=48534526

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2014542644A Active JP5819005B2 (ja) 2011-11-29 2012-11-27 薬学的組成物
JP2015020091A Active JP6095707B2 (ja) 2011-11-29 2015-02-04 薬学的組成物

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2014542644A Active JP5819005B2 (ja) 2011-11-29 2012-11-27 薬学的組成物

Country Status (18)

Country Link
US (4) US9492552B2 (cg-RX-API-DMAC10.html)
EP (2) EP2785352B1 (cg-RX-API-DMAC10.html)
JP (2) JP5819005B2 (cg-RX-API-DMAC10.html)
KR (1) KR101922752B1 (cg-RX-API-DMAC10.html)
CN (2) CN107261152B (cg-RX-API-DMAC10.html)
AR (1) AR089004A1 (cg-RX-API-DMAC10.html)
AU (1) AU2012268889B2 (cg-RX-API-DMAC10.html)
BR (1) BR112014012985B1 (cg-RX-API-DMAC10.html)
CA (1) CA2852716C (cg-RX-API-DMAC10.html)
DK (1) DK2785352T3 (cg-RX-API-DMAC10.html)
ES (1) ES2784629T3 (cg-RX-API-DMAC10.html)
HR (1) HRP20200567T1 (cg-RX-API-DMAC10.html)
IL (1) IL232860B (cg-RX-API-DMAC10.html)
IN (1) IN2014KN01341A (cg-RX-API-DMAC10.html)
SG (2) SG11201401597TA (cg-RX-API-DMAC10.html)
TW (1) TWI552770B (cg-RX-API-DMAC10.html)
WO (1) WO2013078500A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA201402895B (cg-RX-API-DMAC10.html)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2013273764B2 (en) * 2011-11-29 2016-05-05 Zoetis Services Llc Pharmaceutical compositions
SG10201606063RA (en) 2012-01-23 2016-09-29 Sage Therapeutics Inc Neuroactive steroid formulations and methods of treating cns disorders
UA116217C2 (uk) 2012-10-09 2018-02-26 Санофі Пептидна сполука як подвійний агоніст рецепторів glp1-1 та глюкагону
HUE035803T2 (en) 2012-12-21 2018-05-28 Sanofi Sa Dual GLP1 / GIP or trigonal GLP1 / GIP / glucagon agonists
JP6180241B2 (ja) * 2013-08-29 2017-08-16 学校法人同志社 シクロデキストリン誘導体及び医薬組成物
WO2015086730A1 (en) 2013-12-13 2015-06-18 Sanofi Non-acylated exendin-4 peptide analogues
EP3080154B1 (en) 2013-12-13 2018-02-07 Sanofi Dual glp-1/gip receptor agonists
TW201609797A (zh) 2013-12-13 2016-03-16 賽諾菲公司 雙重glp-1/升糖素受體促效劑
WO2015086728A1 (en) 2013-12-13 2015-06-18 Sanofi Exendin-4 peptide analogues as dual glp-1/gip receptor agonists
TW201625670A (zh) 2014-04-07 2016-07-16 賽諾菲公司 衍生自exendin-4之雙重glp-1/升糖素受體促效劑
TW201625669A (zh) 2014-04-07 2016-07-16 賽諾菲公司 衍生自艾塞那肽-4(Exendin-4)之肽類雙重GLP-1/升糖素受體促效劑
TW201625668A (zh) 2014-04-07 2016-07-16 賽諾菲公司 作為胜肽性雙重glp-1/昇糖素受體激動劑之艾塞那肽-4衍生物
US9932381B2 (en) 2014-06-18 2018-04-03 Sanofi Exendin-4 derivatives as selective glucagon receptor agonists
US10858453B2 (en) 2015-04-01 2020-12-08 International Dioxcide, Inc. Stabilized composition for combined odor control and enhanced dewatering
AR105319A1 (es) 2015-06-05 2017-09-27 Sanofi Sa Profármacos que comprenden un conjugado agonista dual de glp-1 / glucagón conector ácido hialurónico
AR105044A1 (es) * 2015-06-18 2017-08-30 Sage Therapeutics Inc Soluciones de esteroides neuroactivos y sus métodos de uso, recipiente
TW201706291A (zh) 2015-07-10 2017-02-16 賽諾菲公司 作為選擇性肽雙重glp-1/升糖素受體促效劑之新毒蜥外泌肽(exendin-4)衍生物
KR101718733B1 (ko) * 2015-08-21 2017-03-22 국제약품 주식회사 레바미피드의 가용화 방법 및 이에 의해 제조된 안구건조증 치료용 액제
NL2015865B1 (en) * 2015-11-27 2017-06-13 Le Vet B V Maropitant Formulation.
GB201609222D0 (en) 2016-05-25 2016-07-06 F2G Ltd Pharmaceutical formulation
KR102583443B1 (ko) * 2017-05-10 2023-09-26 액섬 테라퓨틱스, 인크. 멜록시캄을 포함하는 약학적 조성물
CN110215430A (zh) * 2018-03-02 2019-09-10 刘力 新型可注射的硝酸甘油药物组合物
US12059423B2 (en) * 2018-05-11 2024-08-13 Nanjing Delova Biotech Co., Ltd. Meloxicam composition, pharmaceutical preparation and preparation method and use thereof
KR102141826B1 (ko) * 2018-10-05 2020-08-07 건국대학교 산학협력단 양이온성 베타 시클로덱스트린 올리고머를 이용한 외부 pH 자극 반응형 자가치유성 하이드로젤
WO2020093256A1 (zh) * 2018-11-07 2020-05-14 比卡生物科技(广州)有限公司 一种澄清丙泊酚注射液及其制备方法
WO2020167476A1 (en) * 2019-02-15 2020-08-20 Saol International Limited Injectable phenol formulations and methods of their use
EP3725298A1 (en) 2019-04-16 2020-10-21 Faes Farma, S.A. Stable and preserved pharmaceutical compositions of bilastine
US11819503B2 (en) 2019-04-23 2023-11-21 F2G Ltd Method of treating coccidioides infection
EP3766475A1 (en) 2019-07-15 2021-01-20 OP-Hygiene IP GmbH Wipes
FR3117337B1 (fr) * 2020-12-10 2023-04-28 Centre Hospitalier Univ De Lille Composition pharmaceutique contenant du propofol, une cyclodextrine ou un dérivé de cyclodextrine et un sel pharmaceuticalement acceptable
CN115487138A (zh) * 2021-06-18 2022-12-20 北京万全德众医药生物技术有限公司 别孕烯醇酮注射剂及其制备方法
CN116407497B (zh) * 2021-12-30 2026-05-12 瑞普(天津)生物药业有限公司 一种复方阿法沙龙注射液及其制备方法
KR102848049B1 (ko) 2022-02-14 2025-08-20 주식회사 아크 파라벤계 보존제의 안정성 증진용 조성물 및 이를 포함하는 보존제

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4728509A (en) 1985-08-19 1988-03-01 Takeda Chemical Industries, Ltd. Aqueous liquid preparation
TW401300B (en) * 1992-12-25 2000-08-11 Senju Pharma Co Antiallergic composition for ophthalmic or nasal use
JPH06293638A (ja) * 1993-04-06 1994-10-21 Lion Corp 安定なビタミンa類点眼剤
ZA962214B (en) * 1995-04-10 1996-10-07 Farmarc Nederland Bv Pharmaceutical composition
JP3934705B2 (ja) * 1995-05-26 2007-06-20 ノバルティス ファーマ株式会社 サイクロデキストリン組成物
TW434023B (en) * 1995-09-18 2001-05-16 Novartis Ag Preserved ophthalmic composition
WO2000012137A1 (en) 1998-09-02 2000-03-09 Allergan Sales, Inc. Preserved cyclodextrin-containing compositions
AUPQ633900A0 (en) 2000-03-20 2000-04-15 Jurox Pty Ltd Anaesthetic composition
IN187686B (cg-RX-API-DMAC10.html) * 2000-06-21 2002-06-08 Bharat Serums & Vaccines Ltd
US7034013B2 (en) 2001-03-20 2006-04-25 Cydex, Inc. Formulations containing propofol and a sulfoalkyl ether cyclodextrin
JP2003089632A (ja) * 2001-09-17 2003-03-28 Otsuka Pharmaceut Factory Inc 注射用水性製剤
WO2003063824A2 (en) 2002-02-01 2003-08-07 Shimoda Biotech (Pty) Ltd Pharmaceutical composition
US6869939B2 (en) 2002-05-04 2005-03-22 Cydex, Inc. Formulations containing amiodarone and sulfoalkyl ether cyclodextrin
US20040053895A1 (en) * 2002-09-18 2004-03-18 Bone Care International, Inc. Multi-use vessels for vitamin D formulations
JP4275394B2 (ja) * 2002-12-05 2009-06-10 株式会社大塚製薬工場 注射用シロスタゾール水性製剤
HUE034099T2 (en) * 2004-01-30 2018-01-29 Zoetis Services Llc Antimicrobial preservatives for the delivery of multidose formulations using beta-cyclodextrins for liquid dosage forms
US6969706B1 (en) 2004-05-12 2005-11-29 Allergan, Inc. Preserved pharmaceutical compositions comprising cyclodextrins
EP2767163A1 (en) 2005-02-17 2014-08-20 Abbott Laboratories Transmucosal administration of drug compositions for treating and preventing disorders in animals
JP2009516708A (ja) 2005-11-18 2009-04-23 アストラゼネカ・アクチエボラーグ 液体製剤
BR122020021551B1 (pt) * 2008-11-15 2021-09-21 Melinta Subsidiary Corp Composição farmacêutica antimicrobiana e seu uso
CN102802635B (zh) * 2010-01-21 2014-07-30 吊桥药业有限公司 麻醉药制剂

Similar Documents

Publication Publication Date Title
US12582662B2 (en) Injectable pharmaceutical compositions comprising a cyclodextrin, a hydrophobic drug, a co-solvent and a preservative
JP6272475B2 (ja) 防腐エーテル化シクロデキストリン誘導体含有液体水性医薬組成物
CA2522115A1 (en) A fluoroquinolone aqueous formulation of a ph between 4 and 7 comprising i.a. cyclodextrin, hydroxyacid
JP2012519657A (ja) ベンダムスチン環状多糖組成物
CN101410123A (zh) 低剂量的双氯芬酸和β-环糊精的制剂
AU2013273764B2 (en) Pharmaceutical compositions
NZ706101B2 (en) Methods of preserving injectable pharmaceutical compositions comprising a cyclodextrin and a hydrophobic drug
NZ624592B2 (en) Methods of preserving injectable pharmaceutical compositions comprising a cyclodextrin and a hydrophobic drug
WO2010119368A2 (en) A medicinal cream made using miconazole nitrate and chitosan, and a process to make the same
HK1198325B (en) Stable injectable pharmaceutical compositions comprising 2-hydroxypropyl-beta-cyclodextrin and alfaxalone